- Home
- PRTA vs ANGI Comparison
PRTA vs ANGI Comparison
Compare PRTA & ANGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- ANGI
- Stock Information
- Founded
- PRTA 2012
- ANGI 1995
- Country
- PRTA Ireland
- ANGI United States
- Employees
- PRTA N/A
- ANGI N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- ANGI Advertising
- Sector
- PRTA Health Care
- ANGI Consumer Discretionary
- Exchange
- PRTA Nasdaq
- ANGI Nasdaq
- Market Cap
- PRTA 809.8M
- ANGI 574.1M
- IPO Year
- PRTA N/A
- ANGI 2017
- Fundamental
- Price
- PRTA $9.20
- ANGI $11.60
- Analyst Decision
- PRTA Buy
- ANGI Buy
- Analyst Count
- PRTA 9
- ANGI 8
- Target Price
- PRTA $54.57
- ANGI $28.86
- AVG Volume (30 Days)
- PRTA 557.1K
- ANGI 1.6M
- Earning Date
- PRTA 05-07-2025
- ANGI 05-06-2025
- Dividend Yield
- PRTA N/A
- ANGI N/A
- EPS Growth
- PRTA N/A
- ANGI N/A
- EPS
- PRTA N/A
- ANGI 0.70
- Revenue
- PRTA $135,157,000.00
- ANGI $1,185,112,000.00
- Revenue This Year
- PRTA N/A
- ANGI N/A
- Revenue Next Year
- PRTA $131.71
- ANGI $4.67
- P/E Ratio
- PRTA N/A
- ANGI $16.33
- Revenue Growth
- PRTA 47.92
- ANGI N/A
- 52 Week Low
- PRTA $9.10
- ANGI $11.00
- 52 Week High
- PRTA $25.42
- ANGI $29.20
- Technical
- Relative Strength Index (RSI)
- PRTA 26.58
- ANGI 30.74
- Support Level
- PRTA $9.30
- ANGI $11.25
- Resistance Level
- PRTA $10.45
- ANGI $12.91
- Average True Range (ATR)
- PRTA 0.81
- ANGI 0.94
- MACD
- PRTA -0.15
- ANGI -0.14
- Stochastic Oscillator
- PRTA 2.77
- ANGI 12.17
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About ANGI Angi Inc.
Angi Inc connects quality home service professionals with consumers across different categories, from repairing and remodeling to cleaning and landscaping. It operates through brands like Angi, HomeAdvisor, and Handy. The company has three operating segments, namely, Ads and Leads, Services, and International (Europe and Canada). A majority of its revenue is generated from the Ads and Leads segment, which provides professionals the capability to engage with potential customers, including quoting and invoicing services, and provides consumers with tools and resources to help them find professionals nationwide for home repair, maintenance, and improvement projects. Geographically, the company derives its key revenue from the United States and also has a presence in other countries.